| Literature DB >> 25966804 |
Tineke F M Vergeldt1, Mirjam Weemhoff2, Joanna IntHout3, Kirsten B Kluivers4.
Abstract
INTRODUCTION AND HYPOTHESIS: Pelvic organ prolapse (POP) is a common condition with multifactorial etiology. The purpose of this systematic review was to provide an overview of literature on risk factors for POP and POP recurrence.Entities:
Keywords: Pelvic organ prolapse; Recurrence; Risk factors
Mesh:
Year: 2015 PMID: 25966804 PMCID: PMC4611001 DOI: 10.1007/s00192-015-2695-8
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 2.894
Fig. 1Flow diagram of the selection process
The articles on primary prolapse included in the study
| Reference | Study type |
| Inclusion criteria | Risk factors |
|---|---|---|---|---|
| Progetto Menopausa Italia Study Group [ | Cross-sectional study | 21,449/410 | Nonhysterectomized women around menopause attending an outpatient menopause clinic for general counselling about menopause | BMI, delivery mode, age, parity, smoking, education, birth weight, age at menarche, age at menopause |
| Nygaard et al [ | Cross-sectional study | 270/173 | Nonhysterectomized women enrolled in the WHI Hormone Replacement Therapy clinical randomized trial | BMI, delivery mode, age, smoking, hormone replacement therapy, education, birth weight, waist circumference, occupation, physical activity, family history, age at first and last delivery, pulmonary disease, previous hernia surgery |
| Swift et al [ | Cross-sectional study | 1,004/218 | Women older than 18 years of age presenting for routine gynecological health care | BMI, delivery mode, age, parity, smoking, ethnicity, hormone replacement therapy, birth weight, constipation, occupation, hysterectomy status, menopausal status, chronic illness, income, gravidity |
| Whitcomb et al [ | Cross-sectional study | 1,137/762 | Women between 40 and 69 years of age who, since age 18 years, had been members of the Kaiser Permanente Medical Care Program of Northern California | BMI, age, parity, ethnicity, education, diabetes |
| Slieker-Ten Hove et al [ | Cross-sectional study | 649/227 | A general population of women aged 45 to 85 years | BMI, age, parity, smoking, menopausal status, education, physical activity, family history, urinary incontinence, prolapse during pregnancy |
| Handa et al [ | Prospective cohort study | 1,011/75 | Women between 15 and 50 years of age giving birth to their first child 5 to 10 years before enrolment | Delivery mode |
| Kudish et al [ | Prospective cohort study | 12,650/2,266 | Nonhysterectomized postmenopausal women enrolled in the WHI Estrogen plus Progestin Clinical Trial | BMI, age, parity, smoking, ethnicity, hormone replacement therapy, waist circumference, constipation, physical activity, pulmonary disease, urinary incontinence |
| Dietz et al [ | Cross-sectional study | 605/NAa | Women without previous incontinence or prolapse surgery with symptoms of pelvic floor dysfunction, with data of four-dimensional ultrasound | Levator avulsion, hiatal area on Valsalva |
| Glazener et al [ | Prospective cohort study | 762/182 | Women who delivered over a 12-month period in three maternity units | BMI, delivery mode, parity, age at first birth |
| Yeniel et al [ | Cross-sectional study | 1,964/155 | Women without previous prolapse surgery with benign gynecological disorders | BMI, delivery mode, smoking, menopausal status |
N/n number of women included in the study who underwent physical examination/number of women with pelvic organ prolapse, BMI Body Mass Index in kg/m2, WHI Women’s Health Initiative, NA not available
aNumber of women categorized by type of prolapse: 222 women with cystocele, 159 women with rectocele, 40 women with apical prolapse
Obstetric risk factors for primary prolapse
| Risk factor | Times investigated | Times statistically significant |
| Definition | Adjusted ORa (95 % CI) | Reference |
|---|---|---|---|---|---|---|
| Delivery mode | 7 | 5 | 21,449 | ≥1 cesarean vs no cesarean | OR 0.6 (0.4-1.0) | [ |
| 270 | Per 1 vaginal delivery | OR 1.6 (1.0-2.5)* | [ | |||
| No vaginal deliveries vs 1 or 2 | OR 0.0 (0.0–0.4)* | |||||
| No vaginal deliveries vs 3 or 4 | OR 0.1 (0.0–0.5)* | |||||
| No vaginal deliveries vs ≥5 | OR 0.1 (0.0–0.6)* | |||||
| 3 or 4 vaginal deliveries vs 1 or 2 | OR 0.7 (0.3–1.7) | |||||
| ≥5 vaginal deliveries vs 1 or 2 | OR 1.2 (0.4–3.4) | |||||
| 1,004 | Per 1 vaginal delivery | OR 1.1 (0.9–1.4) | [ | |||
| 1,137 | Cesarean only vs nulliparous | PR 1.1 (1.0–1.2)* | [ | |||
| ≥1 vaginal delivery vs nulliparous | PR 1.1 (1.1–1.2)* | |||||
| 1,011 | All cesarean before full dilation vs all cesarean before labor | RR 0.5 (0.1–2.3) | [ | |||
| ≥1 cesarean after full dilation vs all cesarean before labor | RR 0.7 (0.2–3.1) | |||||
| Spontaneous vaginal births vs all cesarean before labor | RR 5.6 (2.2–14.7)* | |||||
| ≥1 operative vaginal birth vs all cesarean before labor | RR 7.5 (2.7–20.9)* | |||||
| 726 | Cesarean only vs spontaneous vaginal delivery only | OR 0.1 (0.0–0.4)* | [ | |||
| ≥1 forceps delivery vs spontaneous vaginal delivery only | OR 0.6 (0.4–1.0)* | |||||
| ≥1 vacuum extraction, no forceps vs spontaneous vaginal delivery only | OR 0.7 (0.4–1.4) | |||||
| Vaginal and caesarean deliveries vs spontaneous vaginal delivery only | OR 0.5 (0.2–1.0)* | |||||
| 1,964 | Vaginal delivery vs nulliparous | OR 2.9 (1.2–7.2)* | [ | |||
| Cesarean vs nulliparous | OR 0.3 (0.0–2.5) | |||||
| Parity | 6 | 4 | 21,449 | 1 vs 0 | OR 3.1 (1.5–6.4)* | [ |
| 2 vs 0 | OR 3.4 (1.7–6.7)* | |||||
| ≥3 vs 0 | OR 4.6 (2.3–9.1)* | |||||
| 1,004 | Per 1 | OR 1.1 (0.7–1.7) | [ | |||
| 649 | 1 vs 0 | OR 0.4 (0.2–1.2) | [ | |||
| 2 vs 0 | OR 1.6 (0.9–2.7) | |||||
| ≥3 vs 0 | OR 1.5 (0.9–2.8) | |||||
| 12,650 | 1 vs 0 | HR 2.4 (1.7–3.6)* | [ | |||
| 2 vs 0 | HR 3.5 (2.5–4.9)* | |||||
| 3 vs 0 | HR 3.9 (2.8–5.4)* | |||||
| 4 vs 0 | HR 5.1 (3.7–7.1)* | |||||
| ≥5 vs 0 | HR 5.9 (4.2–8.1)* | |||||
| 726 | 2 vs 1 | OR 3.3 (1.5–7.3)* | [ | |||
| 3 vs 1 | OR 3.9 (1.7–9.2)* | |||||
| ≥4 vs 1 | OR 5.2 (2.0–13.4)* | |||||
| 1,964 | Per 1 | OR 1.2 (1.1–1.4)* | [ | |||
| Birth weight | 3 | 1 | 21,449 | >4,500 g vs ≤4,500 g | OR 1.3 (0.9–1.7) | [ |
| 270 | >3,690 g vs ≤3,690 g | NSb | [ | |||
| 1,004 | Per 10 ounces | OR 1.1 (1.0–1.2)* | [ | |||
| Age at first delivery | 2 | 1 | 270 | <20 vs 20–24 vs ≥25 | NSb | [ |
| 726 | 25–29 vs ≤24 | OR 1.5 (0.9–2.3) | [ | |||
| 30–34 vs ≤24 | OR 2.5 (1.5–4.2)* | |||||
| ≥35 vs ≤24 | OR 3.1 (1.4–6.6)* | |||||
| Age at last delivery | 1 | 0 | 270 | ≤29 vs 30–34 vs ≥35 | NSb | [ |
| Gravidity | 1 | 0 | 1,004 | Per 1 | OR 0.9 (0.7–1.2) | [ |
N number of participants, OR odds ratio, 95 % CI 95 % confidence interval, PR prevalence ratio, RR risk ratio, HR hazard ratio, NS not statistically significant
*Statistically significant association (p < 0.05)
aIn some studies PR, RR or HR was used
bNo other data in article
Non-obstetric risk factors for primary prolapse
| Risk factor | Times investigated | Times significantly different |
| Definition | Adjusted ORa (95 % CI) | Reference |
|---|---|---|---|---|---|---|
| Lifestyle factors | ||||||
| BMI | 8 | 5 | 21,449 | 23.8–27.2 vs <23.8 | OR 1.6 (1.2–2.2)* | [ |
| >27.2 vs <23.8 | OR 1.8 (1.3–2.4)* | |||||
| 270 | <27 vs ≥27 | NSb | [ | |||
| 1,004 | 25–30 vs <25 | OR 2.5 (1.2–5.4)* | [ | |||
| >30 vs <25 | OR 2.6 (1.2–5.4)* | |||||
| 1,137 | 25–30 vs <25 | PR 1.1 (1.0–1.1)* | [ | |||
| ≥30 vs <20 | PR 1.1 (1.0–1.1)* | |||||
| 649 | Per kg/m2 | NSb,c | [ | |||
| 12,650 | 25–30 vs <25 | HR 1.3 (1.1–1.4)* | [ | |||
| ≥30 vs <25 | HR 1.3 (1.1–1.5)* | |||||
| 726 | <18.5 vs 18.5–24.9 | OR 1.2 (0.3–5.0) | [ | |||
| 25–29.9 vs 18.5–24.9 | OR 1.3 (0.9–2.0) | |||||
| ≥30 vs 18.5–24.9 | OR 1.5 (0.9–2.4) | |||||
| 1,964 | Per kg/m2 | OR 1.0 (0.9–1.0)* | [ | |||
| Smoking | 6 | 3 | 21,449 | <10 vs no | OR 1.6 (1.0–2.6) | [ |
| 10–20 vs no | OR 1.1 (0.6–2.1) | |||||
| >20 vs no | OR 1.3 (0.7–2.4) | |||||
| 270 | Unknown | NSb,c | [ | |||
| 1,004 | Ever vs never | OR 1.2 (0.6–2.4) | [ | |||
| Current vs never | OR 0.9 (0.3–2.5) | |||||
| 649 | Current vs no | OR 0.5 (0.3–0.8)* | [ | |||
| 12,650 | Past vs never | HR 0.8 (0.7–0.8)* | [ | |||
| Current vs never | HR 0.5 (0.4–0.7)* | |||||
| 1,964 | Yes vs no | OR 0.6 (0.3–0.9)* | [ | |||
| HRT | 3 | 1 | 270 | Unknown | NSb,c | [ |
| 1,004 | Ever vs never | OR 1.0 (0.6–1.7) | [ | |||
| 12,650 | E + P treatment vs placebo | HR 1.1 (1.0–1.3)* | [ | |||
| Past hormone use vs never | HR 1.1 (1.0–1.2) | |||||
| Current hormone use vs never | HR 1.2 (1.0–1.5) | |||||
| Physical activity | 3 | 0 | 270 | Mild vs moderate vs strenuous | NSb,c | [ |
| 649 | Current heavy work vs no | OR 1.3 (0.9–2.0) | [ | |||
| Past heavy work vs no | NSb,c | |||||
| 12,650 | Unknown | HR 1.0 (1.0–1.0) | [ | |||
| Waist circumference | 2 | 1 | 270 | <88 cm vs ≥88 cm | NSb | [ |
| 12,650 | >88 cm vs <88 cm | HR 1.2 (1.0–1.4)* | [ | |||
| Unmodifiable factors | ||||||
| Age | 6 | 4 | 21,449 | 52–55 vs ≤51 | OR 1.5 (1.1–2.0)* | [ |
| ≥56 vs ≤51 | OR 2.6 (2.0–3.4)* | |||||
| 270 | ≥68 vs <68 | NSb,c | [ | |||
| 1,004 | Per 10 years | OR 1.4 (1.1–1.8)* | [ | |||
| 1,137 | Per 10 years | PR 1.0 (1.0–1.1)* | [ | |||
| 649 | Per 1 year | NSb,c | [ | |||
| 12,650 | Per 1 year | HR 1.0 (1.0–1.0)* | [ | |||
| Ethnicity | 3 | 2 | 1,004 | Black vs white | OR 1.2 (0.4–3.3) | [ |
| Hispanic vs white | OR 4.3 (1.8–10.2)* | |||||
| Other vs white | OR 2.4 (0.5–12.1) | |||||
| 1,137 | White vs African–American | PR 1.0 (1.0–1.1) | [ | |||
| Asian vs African–American | PR 1.0 (1.0–1.1) | |||||
| Latina/other vs African–American | PR 1.0 (1.0–1.1) | |||||
| 12,650 | Black vs white | HR 0.5 (0.4–0.7)* | [ | |||
| Hispanic vs white | HR 0.9 (0.7–1.1) | |||||
| Menopausal status | 3 | 1 | 1,004 | No vs yes | OR 0.6 (0.4–1.1)c | [ |
| 649 | Yes vs no | OR 1.3 (0.9–1.9) | [ | |||
| 1,964 | Yes vs no | OR 5.2 (3.4–8.0)* | [ | |||
| Family history | 2 | 0 | 270 | Family with prolapse/UI surgery | NSb,c | [ |
| 649 | Mother with prolapse vs no | OR 1.6 (1.0–2.4) | [ | |||
| Age at menopause | 1 | 0 | 21,449 | 49–51 vs <48 | OR 0.9 (0.7–1.3) | [ |
| ≥52 vs <48 | OR 1.1 (0.8–1.5) | |||||
| Age at menarche | 1 | 0 | 21,449 | 12–13 vs <11 | OR 0.8 (0.6–1.0) | [ |
| ≥14 vs <11 | OR 1.0 (0.8–1.3) | |||||
| Comorbidity | ||||||
| Urinary incontinence | 2 | 1 | 649 | UI surgery vs no | OR 2.2 (0.9–5.4) | [ |
| 12,650 | Stress UI vs never | HR 1.1 (1.0–1.3) | [ | |||
| Urge UI vs never | HR 1.3 (1.1–1.5)* | |||||
| Mixed UI vs never | HR 1.2 (1.0–1.5)* | |||||
| Other UI vs never | HR 1.0 (0.8–1.4) | |||||
| Pulmonary disease | 2 | 0 | 270 | Asthma yes vs no | NSb,c | [ |
| 12,650 | Asthma | HR 1.0 (0.8–1.2) | [ | |||
| Emphysema | HR 1.2 (0.9–1.6) | |||||
| Constipation | 2 | 0 | 1,004 | Yes vs no | NSc,d | [ |
| 12,650 | Moderate/severe vs no | HR 1.0 (0.8–1.2) | [ | |||
| Diabetes | 1 | 1 | 1,137 | Yes vs no | PR 1.1 (1.1–1.1)* | [ |
| Chronic illness | 1 | 0 | 1,004 | Any vs none | OR 1.1 (0.5–2.1)c | [ |
| Hysterectomy status | 1 | 0 | 1,004 | Yes vs no | OR 1.1 (0.7–1.6)c | [ |
| Previous hernia surgery | 1 | 0 | 270 | Yes vs no | NSb,c | [ |
| POP in pregnancy | 1 | 0 | 649 | Yes vs no | OR 1.4 (1.0–2.1) | [ |
| Social factors | ||||||
| Education | 4 | 2 | 21,449 | Intermediate school vs elementary | OR 0.6 (0.5–0.8)* | [ |
| High school/university vs elementary | OR 0.6 (0.4–0.8)* | |||||
| 270 | ≤High school vs > high school | OR 2.2 (1.1–4.2)* | [ | |||
| 1,137 | ≥College vs < college | PR 1.0 (1.0–1.1) | [ | |||
| 649 | Intermediate school vs unknown | OR 0.7 (0.4–1.1) | [ | |||
| Occupation | 2 | 0 | 270 | Previous employment history | NSb,c | [ |
| 1,004 | Labor vs nonlabor | OR 1.2 (0.6–2.3)c | [ | |||
| Income | 1 | 1 | 1,004 | Medium vs high | OR 0.3 (0.1–0.8)* | [ |
| Low vs high | OR 1.4 (0.5–3.9) | |||||
| Pelvic floor factors | ||||||
| Levator defect | 1 | 1 | 605 | Unilateral vs no avulsion | OR 2.8 (1.4–5.4)* | [ |
| Bilateral vs no avulsion | OR 4.0 (1.8–9.1)* | |||||
| Hiatus genitalis | 1 | 1 | 605 | Hiatal area on Valsalva per cm2 | OR 1.1 (1.1–1.1)* | [ |
HRT hormone replacement therapy, E + P estrogen plus progesterone, UI urinary incontinence, POP pelvic organ prolapse
*Statistically significant association (p < 0.05)
aIn some studies hazard ratio or prevalence ratio was used
bNo other data in article
cData of univariate analysis, not in multivariate analysis
dDescribed in article twice with different results, both not significant
Articles on prolapse recurrence included
| Reference | Study type |
| Inclusion criteria | Follow-up | Risk factors |
|---|---|---|---|---|---|
| Tegerstedt and Hammarstrom [ | Retrospective cohort study | 128/56 | Women who had prolapse surgery (Manchester procedure, anterior colporrhaphy, posterior colporrhaphy, cervix amputation, vaginal hysterectomy, enterocele repair, abdominal vaginosacropexy or combinations) | 10–12 years | Age, preoperative stage, BMI, pulmonary disease, smoking, urinary incontinence, complicated delivery, previous pelvic floor surgery, heavy lifting, incomplete emptying of bladder, constipation, fecal incontinence, surgeon’s experience |
| Whiteside et al [ | Prospective cohort study | 176/102 | Women who underwent anterior colporrhaphy, with or without hysterectomy, posterior colporrhaphy, bladder neck plication, vaginal vault suspension, enterocele repair, culdoplasty, bladder neck suspension or retropubic paravaginal defect repair | 1 year | Age, preoperative stage, hysterectomy status, number of sites involved, urinary incontinence, previous prolapse surgery, menopausal status, diabetes, site of most advanced preoperative prolapse, previous incontinence surgery |
| Diez-Itza et al [ | Retrospective cohort study | 134/42 | Women who had vaginal hysterectomy, anterior colporrhaphy or posterior colporrhaphy for prolapse | 5 years | Age, preoperative stage, BMI, constipation, pulmonary disease, parity, family history, surgeon’s experience, weight, abdominal hernias, intense physical exercise, levator muscle contraction |
| Salvatore et al [ | Prospective cohort study | 360/36 | Women who underwent prolapse surgery without using grafts (vaginal hysterectomy, and/or anterior colporrhaphy and/or posterior colporrhaphy) | 26 months | Age, preoperative stage, BMI, constipation, hysterectomy status, pulmonary disease, parity, genital hiatus, menopausal status, birth weight |
| Weemhoff et al [ | Prospective cohort study | 156/80 | Women who underwent anterior colporrhaphy, with or without hysterectomy, posterior colporrhaphy or sacrospinous fixation | 2 years | Age, preoperative stage, BMI, constipation, parity, number of sites involved, family history, concomitant surgery, previous prolapse surgery, complicated delivery, levator defect |
N/n number of women included in the study who underwent physical examination/number of women with pelvic organ prolapse recurrence
Risk factors for prolapse recurrence
| Risk factor | Times investigated | Times statistically significant |
| Definition | Adjusted OR (95 % CI) | Reference |
|---|---|---|---|---|---|---|
| Obstetric factors | ||||||
| Parity | 3 | 0 | 134 | 0 vs ≥1 | NSa | [ |
| 360 | Per 1 | NSa | [ | |||
| 156 | Per 1 | OR 0.9 (0.7–1.2)b | [ | |||
| Complicated delivery | 2 | 0 | 128 | Yes vs no | OR 1.4 (0.9–1.9)b | [ |
| 156 | Assisted vs no | OR 0.8 (0.3–2.1)b | [ | |||
| Birth weight | 1 | 0 | 360 | >4,000 g vs ≤4,000 g | OR 1.8 (0.9–3.6)b | [ |
| Age at last delivery | 1 | 0 | 134 | Per 1 | NSa | [ |
| Lifestyle factors | ||||||
| BMI | 4 | 0 | 128 | >25 vs ≤25 | OR 1.2 (0.9–1.8)b | [ |
| 134 | Per kg/m2 | NSa | [ | |||
| 360 | >30 vs ≤30 | OR 1.2 (0.5–2.8)b | [ | |||
| 156 | Per kg/m2 | OR 1.0 (0.9–1.1)b | [ | |||
| Weight | 1 | 1 | 134 | >65 vs ≤65 | OR 4.0 (1.6–9.6)* | [ |
| Intense physical exercise | 1 | 0 | 134 | Yes vs no | NSa | [ |
| Heavy lifting | 1 | 0 | 128 | Yes vs no | OR 1.1 (0.7–1.6)b | [ |
| Smoking | 1 | 0 | 128 | Yes vs no | OR 1.4 (0.8–2.5)b | [ |
| Unmodifiable factors | ||||||
| Age | 5 | 2 | 128 | >70 vs ≤70 | NSa | [ |
| 176 | <50 vs 50–59 vs 60–69 vs ≥70 <60 vs ≥60 | NSa
| [ | |||
| 134 | <60 vs ≥60 | OR 4.1 (1.6–10.4)* | [ | |||
| 360 | Age per year | NSa | [ | |||
| 156 | Age per year | NSa | [ | |||
| Family history | 2 | 1 | 134 | Yes vs no | NSa | [ |
| 156 | Yes vs no | OR 2.4 (1.2–4.9)* | [ | |||
| Menopausal status | 2 | 0 | 176 | Yes vs no | NSa | [ |
| 360 | Yes vs no | NSa | [ | |||
| Comorbidity | ||||||
| Constipation | 4 | 0 | 128 | Yes vs no | OR 1.1 (0.7–1.7)b | [ |
| 134 | Yes vs no | NSa | [ | |||
| 360 | Yes vs no | OR 0.6 (0.3–1.4)b | [ | |||
| 156 | Yes vs no | OR 1.0 (0.4–2.3)b | [ | |||
| Previous pelvic floor surgery | 3 | 1 | 128 | Yes vs no | OR 1.8 (1.1–2.8)b* | [ |
| 176 | Yes vs no | NSa | [ | |||
| 156 | Yes vs no | OR 1.4 (0.5–4.0)b | [ | |||
| Pulmonary disease | 3 | 0 | 128 | Yes vs no | OR 1.3 (0.7–2.4)b | [ |
| 134 | Yes vs no | NSa | [ | |||
| 360 | Yes vs no | OR 1.6 (0.7–3.8)b | [ | |||
| Any incontinence preoperative | 2 | 1 | 128 | Yes vs no | OR 1.4 (1.0–2.1)b* | [ |
| 176 | Yes vs no | NSa | [ | |||
| Previous hysterectomy | 2 | 0 | 176 | Yes vs no | NSa | [ |
| 360 | Yes vs no | OR 0.6 (0.3–1.2)b | [ | |||
| Incomplete emptying of bladder | 1 | 0 | 128 | Yes vs no | OR 1.3 (0.9–1.9)b | [ |
| Fecal incontinence | 1 | 0 | 128 | Yes vs no | NSa | [ |
| Diabetes | 1 | 0 | 176 | Yes vs no | NSa | [ |
| Abdominal hernias | 1 | 0 | 134 | Yes vs no | NSa | [ |
| Surgical factors | ||||||
| Preoperative stage | 5 | 4 | 128 | Stage IV vs < stage IV | OR 1.5 (0.9–2.4) | [ |
| 176 | Stage III or IV vs stage II | OR 2.7 (1.3–5.3)* | [ | |||
| 134 | Stage III or IV vs stage I or II | OR 3.9 (1.2–13.0)* | [ | |||
| 360 | Stage III or IV vs stage I or II | OR 2.4 (1.1–5.1)* | [ | |||
| 156 | Stage III or IV vs stage I or II | OR 2.0 (1.0–4.1)* | [ | |||
| Surgeon’s experience | 2 | 0 | 128 | Senior vs no senior surgeon | OR 0.8 (0.5–1.3)b | [ |
| 134 | Junior vs no junior surgeon | NSa | [ | |||
| Number. of sites involved preoperative | 2 | 0 | 176 | 1 vs 2 vs 3 | NSa | [ |
| 156 | 2 vs 1 | OR 1.1 (0.5–2.5)b
| [ | |||
| Concomitant surgery | 1 | 1 | 156 | Sacrospinal fixation vs no | OR 6.5 (2.0–21.2)* | [ |
| Pelvic floor factors | ||||||
| Levator defect | 1 | 1 | 156 | Yes vs no | OR 2.3 (1.1–4.8)* | [ |
| Hiatus genitalis | 1 | 0 | 360 | Unknown | OR 1.4 (0.5–2.3)b | [ |
| Levator muscle contraction | 1 | 0 | 134 | Oxford scale <3 vs ≥3 | NSa | [ |
| Site of most advanced prolapse | 1 | 0 | 176 | Anterior vs apex vs posterior | NSa | [ |
*Statistically significant association (p < 0.05)
aNo other data in article
bData of univariate analysis, not in multivariate analysis